Revance Therapeutics, Inc. (NASDAQ:RVNC) Receives Average Rating of "Buy" from Brokerages

Retrieved on: 2021-02-09 07:41:15

Tags for this article:

Click the tags to see associated articles and topics

Revance Therapeutics, Inc. (NASDAQ:RVNC) Receives Average Rating of "Buy" from Brokerages. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 5,012,352 shares of the biopharmaceutical company's stock valued at $142,051,000 after buying an additional 131,164 ...

Article found on: www.marketbeat.com